SOBI links with Savient for co-promotion of Kineret in USA


Swedish Orphan Biovitrum (STO: SOBI) says it has entered into an agreement with USA-based Savient Pharmaceuticals…

Anti-Arthritics/RheumaticsInflammatory diseasesKineretLicensingMarkets & MarketingNorth AmericaPharmaceuticalSavient PharmaceuticalsSobiSwedish Orphan Biovitrum

Swedish Orphan Biovitrum and Dongbao in cross-licensing deal to market each other’s products in China and Europe


Stockholm-based Swedish Orphan Biovitrum (SOB) and Chinese firm Dongbao intend to form a strategic commercial…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyDongbaoEuropeKineretKiobrinaLicensingPharmaceuticalSwedish Orphan Biovitrum

Back to top